S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known if surgery plus combination chemotherapy is more effective than surgery alone for
non-small cell lung cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of surgery with or without
combination chemotherapy in treating patients who have non-small cell lung cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
Eastern Cooperative Oncology Group National Cancer Institute (NCI) North Central Cancer Treatment Group Radiation Therapy Oncology Group